Acacplatin-RB, a cisplatin analog having acetylacetone-appended to boron-dipyrromethene (BODIPY) dye, exhibits mitochondrial localization and remarkable apoptotic red-light induced photodynamic therapy (PDT) forming singlet oxygen as reactive oxygen species. Moreover, this complex demonstrated decrease in mitochondrial membrane potential, disruption of microtubules under photoinduced conditions and anti-metastatic properties from wound-healing assay.
Abstract
Cisplatin-derived platinum(II) complexes [Pt(NH3)2(pacac)](NO3) (1, DPP-Pt) and [Pt(NH3)2(Acac-RB)](NO3) (2, Acacplatin-RB), where Hpacac is 1,3-diphenyl-1,3-propanedione and HAcac-RB is a red-light active distyryl-BODIPY-appended acetylacetone ligand, are prepared, characterized and their photodynamic therapy (PDT) activity studied (RB abbreviated for red-light BODIPY). Complex 2 displayed an intense absorption band at λ=652 nm (ϵ=7.3×104 M−1 cm−1) and 601 nm (ϵ=3.1×104 M−1 cm−1) in 1 : 1 DMSO-DPBS (Dulbecco's Phosphate Buffered Saline). Its emission profile includes a broad maximum at ~673 nm (λex=630 nm). The fluorescence quantum yield (ΦF) of HAcac-RB and 2 are 0.19 and 0.07, respectively. Dichlorodihydrofluorescein diacetate and 1,3-diphenylisobenzofuran assay of complex 2 indicated photogeneration of singlet oxygen (ΦΔ: 0.36) as reactive oxygen species (ROS). Light irradiation caused only minor extent of ligand release forming chemo-active cisplatin analogue. The complex showed ~70–100 fold enhancement in cytotoxicity on light exposure in A549 lung cancer cells and MDA-MB-231 multidrug resistant breast cancer cells, giving half maximal inhibitory concentration (IC50) of 0.9–1.8 μM. Confocal imaging showed its mitochondrial localization and complex 2 exhibited anti-metastasis properties. Immunostaining of β-tubulin and Annexin V-FITC/propidium iodide staining displayed complex 2 induced photo-selective microtubule rupture and cellular apoptosis, respectively.